Latest Insights - page 17 | BiopharmaTrend

How Big Pharma Adopts AI To Boost Drug Discovery

(Last updated: October 2025) Since 1950, when Alan Turing introduced the concept of 'thinking machines', artificial intelligence has steadily advanced—from the rise of neural networks in the 1980s to the …

Continue ›››

How Lantern Pharma's AI-driven Approach Enables Precision Oncology

Sanofi Licenses BenchSci’s Neurosymbolic AI for Global Preclinical R&D

Sanofi has signed a three-year license agreement with Toronto-based BenchSci to deploy the ASCEND platform across its global preclinical research teams. The partnership marks a move to embed neurosymbolic AI …

Continue ›››

12 Emerging Companies to Watch in Neurotech Space

Brain-computer interface (BCI) technologies are rapidly becoming the spotlight of the neurotech industry, with Neuralink at the forefront. Recently, Neuralink implanted its first brain chip in a human, marking a …

Continue ›››

The Pivotal Role of AI in Clinical Trials: From Digital Twins to Synthetic Control Arms

Artificial Intelligence (AI) is redefining the clinical trial process, offering solutions that address long-standing challenges in drug development. The traditional clinical trial model is fraught with inefficiencies: trials can take …

Continue ›››

AI Model Built on Transformer Architecture Maps 1,300 Mouse Brain Regions in Data-Driven Atlas

Researchers at UCSF and the Allen Institute have developed a transformer-based AI model CellTransformer that maps 1,300 brain regions and subregions in the mouse brain, including previously uncharted subregions. The model was …

Continue ›››

5 AI-Powered Companies Transforming the Future of Fertility Care

The field of fertility treatments is experiencing a surge in demand, fueled by several significant factors. A shift towards starting families at a later age, the increasing number of same-sex …

Continue ›››

AstraZeneca Signs $555 Million AI Deal For CRISPR Therapies

AstraZeneca agreed to a collaboration worth up to $555m in regulatory and commercial milestones with San Francisco–based Algen Biotechnologies, securing exclusive rights to develop and commercialise therapies from CRISPR gene-editing …

Continue ›››

Singapore’s Nanyang Biologics Plans to Go Public on Nasdaq in US $1.5 Billion SPAC Deal

Singapore’s Nanyang Biologics (NYB), a company working at the intersection of biodiversity and artificial intelligence, is preparing to list on Nasdaq through a US$ 1.5 billion business combination with RF Acquisition …

Continue ›››

BigHat Introduces AI Platform for Antibody Design and Optimization

BigHat Biosciences, headquartered in San Mateo, California, has unveiled the Reccy Antibody Design Studio (RADS), a fully integrated platform combining machine learning with high-throughput experimental validation for antibody development. The …

Continue ›››

DARPA Funds PolarisQB to Advance Quantum-Aided Drug Design

The U.S. Defense Advanced Research Projects Agency (DARPA) has awarded Polaris Quantum Biotech (PolarisQB) an Embedded Entrepreneurship Initiative (EEI) grant to accelerate commercialization of its quantum computing platform for drug …

Continue ›››

17 Companies Pioneering AI Foundation Models in Pharma and Biotech

Foundation models represent a relatively new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. Foundation models are a class of large-scale machine learning models, typically …

Continue ›››